No Data
List of cloud penetration stocks [Ichimoku Kinko Hyo - List of cloud penetration stocks]
○ List of stocks breaking through the clouds Market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo Main Board <1333> Maruha Nichiro 3142 3111.25 3082 <1720> Tokyu Construction 7747 70.5751 <1879> Shin-Nihon Kensei 1527 1489.5 1507 <1925> Daiwa House 4993 49634843.5 <1926> Light Industry 2492 2487.25 2425 <200
List of conversion stocks (part 3) [Parabolic Cigna Corp conversion stocks list]
○ List of Stocks Turning to Sell in the Market Code Stock Name Closing Price SAR Tokyo Main Board <4206> Aica Kogyo 3297 3468 <4218> Nichiban 20082155 <4229> GunEi Chemical 29843095 <4323> Nissys Technology 18051911 <4333> Toho System 12361294 <4337> Pia 26472940 <4345> CTS Corp 772813 <4362>
Zeria Pharmaceutical To Go Ex-Dividend On March 28th, 2025 With 23 JPY Dividend Per Share
March 27th (Japan Standard Time) - $Zeria Pharmaceutical(4559.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 23 JPY dividend per share. The ex-
Rating information (Target Price change - part 2) = Mercari, Zeria Pharmaceutical ETC.
◎Okasan Securities (three-tier system: Bullish > Neutral > Bearish) Mercari <4385.T> -- "Neutral" → "Neutral", 2200 yen → 2500 yen ◎Tokai Tokyo Securities (three-tier system: Outperform > Neutral > Underperform) Zeria Pharmaceutical <4559.T> -- "Outperform" → "Outperform", 3370 yen → 3000 yen ◎Marusan Securities (three-tier system: Buy > Neutral > Sell) Toyo Gosei <4970.T> -- "Buy" → "Buy", 10000 yen → 7700 yen Provided by: Ue
List of convertible stocks (Part 1) [List of Parabolic Signal convertible stocks]
○ List of stocks for Buy conversion in the market Code Stock Name Close Price SAR Tokyo Main Board <2109> DM Mitsui Sugar 3475 3355 <2181> Persol HD 241 225 <2269> Meiji HD 3070 2871 <2292> S FOODS 2372 2296 <2331> ALSOK 10921040 <2378> Renaissance 1
Zeria Pharmaceutical, Tokai Tokyo Securities has raised the Target Price to 3,370 yen.
Tokai Tokyo Securities has maintained a bullish "outperform" rating for Zeria Pharmaceutical Industry <4559.T> as of the 21st. The target price has been raised from 3,170 yen to 3,370 yen. For the fiscal year ending March 2025, operating profit is expected to exceed plans due to growth in the two main business segments. Provided by Wealth Advisor.